You are here
- Home
AstraZeneca products
AstraZeneca is one of the world's major research-based pharmaceutical companies. AstraZeneca aims to be the first with new ideas and innovations in all areas of its activity.
It has a well-established reputation for researching and developing new drugs. This is backed by a strong research base, with some 12,000 employees dedicated to R+D at 17 research centres in 8 countries. R+D investment totals over $5 billion.
The company first became involved in cancer research in the 1960’s and has developed new drugs for the treatment of cancer.
For information about our products used in prostate cancer please see below:
It has a well-established reputation for researching and developing new drugs. This is backed by a strong research base, with some 12,000 employees dedicated to R+D at 17 research centres in 8 countries. R+D investment totals over $5 billion.
The company first became involved in cancer research in the 1960’s and has developed new drugs for the treatment of cancer.
For information about our products used in prostate cancer please see below:
| CASODEX (bicalutamide) 50mg | International Prescribing Information |
| CASODEX (bicalutamide) 150mg | International Prescribing Information |
| ZOLADEX (goserelin) 10.8mg | International Prescribing Information |
| ZOLADEX (goserelin) 3.6mg | International Prescribing Information |
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
